Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on November 10, 2020. The filing primarily addresses significant changes in executive leadership and the board of directors, effective January 1, 2021, and December 31, 2020, respectively. Additionally, the filing references the company's financial results for the quarter ended September 30, 2020, which were announced via a press release incorporated by reference.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is referenced but not detailed in the body of this 8-K.
Material Changes and Leadership Transitions
- Chief Financial Officer: J. Patrick Nelli will step down as CFO and assume the newly created role of President, effective January 1, 2021.
- New CFO: Bryan Hunt, currently Senior Vice President of Financial Planning and Analysis, will be appointed Chief Financial Officer, effective January 1, 2021. Mr. Hunt has been with the company since April 2014.
- Chief Accounting Officer: Jason Alger, currently Senior Vice President of Finance, will be appointed Chief Accounting Officer, effective January 1, 2021. Mr. Alger has served as Controller since April 2013.
- Board Resignation: Mike Dixon resigned from the Board of Directors and the nominating and corporate governance committee, effective December 31, 2020. The resignation is not the result of any disagreement with the company.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or risk factors. It notes that the new officers (Hunt and Alger) will participate in the Executive Severance Plan and that indemnification agreements are expected to be entered into. The financial outlook is referenced only by the inclusion of the quarterly results press release.
Investor Verification Checklist
- Review Exhibit 99.1 for specific Q3 2020 financial results, including revenue growth and profitability metrics.
- Confirm the transition timeline for the CFO and President roles to ensure continuity in financial reporting.
- Verify the terms of the Executive Severance Plan and indemnification agreements for the newly appointed officers.
- Assess the impact of Mike Dixon's departure on the board's composition and governance committees.